MAS
BIO icon

Meeder Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Meeder Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Sell
775
-3
-0.4% -$851 0.01% 658
2026
Q1 		$217K Sell
778
-35
-4% -$10.1K 0.01% 631
2025
Q4 		$246K Buy
813
+67
+9% +$20.9K 0.01% 584
2025
Q3 		$209K Buy
+746
New +$203K 0.01% 590

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Meeder Advisory Services's BIO Position: Q2 2026 in Review

Meeder Advisory Services reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.39% in Q2 2026, selling an estimated $851 and leaving 775 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #658.

Meeder Advisory Services first reported a position in BIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $246K in Q4 2025. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Meeder Advisory Services held 775 shares of Bio-Rad Laboratories Class A worth $228K as of Q2 2026.
  • Meeder Advisory Services sold 3 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $851.
  • Bio-Rad Laboratories Class A made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #658 holding.
  • Meeder Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 4 quarters since.
  • Meeder Advisory Services's Bio-Rad Laboratories Class A position peaked at $246K in Q4 2025.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.